TABLE OF CONTENTS
|  | | | Volume 112, Issue 1 (1-216)
Published online 6 January 2015
|  | In this issue
 Editorial
Minireviews
Review
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology
Also new today
 Advance online publication
Digital Edition
| | | | | | Advertisement | | | | | | Editorial | Top | | Combining targeted therapeutics in the era of precision medicine D Papadatos-Pastos, M J De Miguel Luken and Timothy A Yap Br J Cancer 2015 112: 1-3; 10.1038/bjc.2014.558 Full Text | | Minireviews | Top | | TMPRSS4: an emerging potential therapeutic target in cancer A L de Aberasturi and A Calvo Br J Cancer 2015 112: 4-8; advance online publication, September 9, 2014; 10.1038/bjc.2014.403 Abstract | Full Text | | | | It is not all about BRCA: Cullin-Ring ubiquitin Ligases in ovarian cancer A Carlucci and V D'Angiolella Br J Cancer 2015 112: 9-13; advance online publication, December 9, 2014; 10.1038/bjc.2014.594 Abstract | Full Text | | Review | Top | | Comparing comparators: a look at control arms in kidney cancer studies over the years S Bracarda, C Porta, M Sisani, F Marrocolo, C Paglino, A Hamzaj, S D Buono and C N Sternberg Br J Cancer 2015 112: 14-19; advance online publication, November 6, 2014; 10.1038/bjc.2014.240 Abstract | Full Text | | Clinical Studies | Top | | Familial diagnostic experiences in paediatric oncology N T Evans, C E Wakefield, J K McLoone and R J Cohn Br J Cancer 2015 112: 20-23; advance online publication, September 30, 2014; 10.1038/bjc.2014.516 Abstract | Full Text | | | | A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours B A Wilky, M A Rudek, S Ahmed, D A Laheru, D Cosgrove, R C Donehower, B Nelkin, D Ball, L A Doyle, H Chen, X Ye, G Bigley, C Womack and N S Azad Br J Cancer 2015 112: 24-31; advance online publication, September 30, 2014; 10.1038/bjc.2014.515 Abstract | Full Text | | | | A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes A B Miah, U Schick, S A Bhide, M-T Guerrero-Urbano, C H Clark, A M Bidmead, S Bodla, L Del Rosario, K Thway, P Wilson, K L Newbold, K J Harrington and C M Nutting Br J Cancer 2015 112: 32-38; advance online publication, December 4, 2014; 10.1038/bjc.2014.553 Abstract | Full Text | | | | Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed M Kunneman, C A M Marijnen, T Rozema, H M Ceha, D A R H Grootenboers, K J Neelis, A M Stiggelbout and A H Pieterse Br J Cancer 2015 112: 39-43; advance online publication, October 21, 2014; 10.1038/bjc.2014.546 Abstract | Full Text | | | | Increased stomach cancer risk following radiotherapy for testicular cancer M Hauptmann, S D Fossa, M Stovall, F E van Leeuwen, T B Johannesen, P Rajaraman, E S Gilbert, S A Smith, R E Weathers, B M P Aleman, M Andersson, R E Curtis, G M Dores, J F Fraumeni, P Hall, E J Holowaty, H Joensuu, M Kaijser, R A Kleinerman, F Langmark, C F Lynch, E Pukkala, H H Storm, L Vaalavirta, A W van den Belt-Dusebout, L B Travis and L M Morton Br J Cancer 2015 112: 44-51; advance online publication, November 4, 2014; 10.1038/bjc.2014.552 Abstract | Full Text | | | | Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer L Bazzola, C Foroni, D Andreis, V Zanoni, M R Cappelletti, G Allevi, S Aguggini, C Strina, M Milani, S Venturini, F Ferrozzi, R Giardini, R Bertoni, H Turley, K Gatter, P G Petronini, S B Fox, A L Harris, M Martinotti, A Berruti, A Bottini, A R Reynolds and D Generali Br J Cancer 2015 112: 52-60; advance online publication, December 2, 2014; 10.1038/bjc.2014.563 Abstract | Full Text | | | | Quantitative assessment of miR34a as an independent prognostic marker in breast cancer Seema Agarwal, J Hanna, M E Sherman, J Figueroa and D L Rimm Br J Cancer 2015 112: 61-68; advance online publication, December 4, 2014; 10.1038/bjc.2014.573 Abstract | Full Text | | | | A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis M Biselli, F Conti, A Gramenzi, M Frigerio, A Cucchetti, G Fatti, M D'Angelo, M Dall'Agata, E G Giannini, F Farinati, F Ciccarese, P Andreone, M Bernardi and F Trevisani Br J Cancer 2015 112: 69-76; advance online publication, October 14, 2014; 10.1038/bjc.2014.536 Abstract | Full Text | | Translational Therapeutics | Top | | New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53 D Sorriento, C Del Giudice, A Bertamino, M Ciccarelli, I Gomez-Monterrey, P Campiglia, E Novellino, M Illario, B Trimarco, N De Luca and G Iaccarino Br J Cancer 2015 112: 77-85; advance online publication, November 25, 2014; 10.1038/bjc.2014.577 Abstract | Full Text | | | | Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma C D Santos, A Tijeras-Raballand, M Serova, S Sebbagh, K Slimane, S Faivre, A de Gramont and E Raymond Br J Cancer 2015 112: 86-94; advance online publication, November 25, 2014; 10.1038/bjc.2014.578 Abstract | Full Text | | | | PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients A D'Incecco, M Andreozzi, V Ludovini, E Rossi, A Capodanno, L Landi, C Tibaldi, G Minuti, J Salvini, E Coppi, A Chella, G Fontanini, M E Filice, L Tornillo, R M Incensati, S Sani, L Crinò, L Terracciano and F Cappuzzo Br J Cancer 2015 112: 95-102; advance online publication, October 28, 2014; 10.1038/bjc.2014.555 Abstract | Full Text | | | | Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer H J Lee, A N Seo, E J Kim, M H Jang, Y J Kim, J H Kim, S-W Kim, H S Ryu, I A Park, S-A Im, G Gong, K H Jung, H J Kim and S Y Park Br J Cancer 2015 112: 103-111; advance online publication, October 28, 2014; 10.1038/bjc.2014.556 Abstract | Full Text | | Molecular Diagnostics | Top | | Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma H Yang, P Lan, Z Hou, Y Guan, J Zhang, W Xu, Z Tian and C Zhang Br J Cancer 2015 112: 112-121; advance online publication, November 13, 2014; 10.1038/bjc.2014.547 Abstract | Full Text | | | | The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC P W Voorneveld, L L Kodach, R J Jacobs, C J M van Noesel, M P Peppelenbosch, K S Korkmaz, I Molendijk, E Dekker, H Morreau, G W van Pelt, R A E M Tollenaar, W Mesker, L J A C Hawinkels, M Paauwe, H W Verspaget, D T Geraets, D W Hommes, G J A Offerhaus, G R van den Brink, P ten Dijke and J C H Hardwick Br J Cancer 2015 112: 122-130; advance online publication, November 13, 2014; 10.1038/bjc.2014.560 Abstract | Full Text | | | | MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer H Listing, W A Mardin, S Wohlfromm, S T Mees and J Haier Br J Cancer 2015 112: 131-139; advance online publication, November 25, 2014; 10.1038/bjc.2014.587 Abstract | Full Text | | | | Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies F Huber, M Montani, T Sulser, R Jaggi, P Wild, H Moch, H Gevensleben, M Schmid, S Wyder and G Kristiansen Br J Cancer 2015 112: 140-148; advance online publication, November 25, 2014; 10.1038/bjc.2014.588 Abstract | Full Text | | Epidemiology | Top | | Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden J Ji, J Sundquist and K Sundquist Br J Cancer 2015 112: 149-152; advance online publication, October 14, 2014; 10.1038/bjc.2014.544 Abstract | Full Text | | | | Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark S Arnspang, A Pottegård, S Friis, O Clemmensen, K E Andersen, J Hallas and D Gaist Br J Cancer 2015 112: 153-156; advance online publication, October 7, 2014; 10.1038/bjc.2014.527 Abstract | Full Text | | | | Statin use and risk for ovarian cancer: a Danish nationwide case–control study L Baandrup, C Dehlendorff, S Friis, J H Olsen and S K Kjær Br J Cancer 2015 112: 157-161; advance online publication, November 13, 2014; 10.1038/bjc.2014.574 Abstract | Full Text | | | | Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort J Ose, R T Fortner, H Schock, P H Peeters, N C Onland-Moret, H B Bueno-de-Mesquita, E Weiderpass, I T Gram, K Overvad, A Tjonneland, L Dossus, A Fournier, L Baglietto, A Trichopoulou, V Benetou, D Trichopoulos, H Boeing, G Masala, V Krogh, A Matiello, R Tumino, M Popovic, M Obón-Santacana, N Larrañaga, E Ardanaz, M-J Sánchez, V Menéndez, M-D Chirlaque, R C Travis, K-T Khaw, J Brändstedt, A Idahl, E Lundin, S Rinaldi, E Kuhn, I Romieu, M J Gunter, M A Merritt, E Riboli and R Kaaks Br J Cancer 2015 112: 162-166; advance online publication, November 4, 2014; 10.1038/bjc.2014.566 Abstract | Full Text | | | | Breast cancer incidence and mortality in a transitioning Chinese population: current and future trends I O L Wong, C M Schooling, B J Cowling and G M Leung Br J Cancer 2015 112: 167-170; advance online publication, October 7, 2014; 10.1038/bjc.2014.532 Abstract | Full Text | | | | Irritable bowel syndrome and the incidence of colorectal neoplasia: a prospective cohort study with community-based screened population in Taiwan H-C Chang, A M-F Yen, J C-Y Fann, S Y-H Chiu, C-S Liao, H-H Chen, K-C Yang, L-S Chen and Y-M Lin Br J Cancer 2015 112: 171-176; advance online publication, December 4, 2014; 10.1038/bjc.2014.575 Abstract | Full Text | | | | Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study S-H Chien, C-J Liu, Y-C Hong, C-J Teng, Y-W Hu, C-C Shen, F-C Ku, S-C Chen, C-M Yeh, T-J Chiou, J-P Gau and C-H Tzeng Br J Cancer 2015 112: 177-184; advance online publication, October 14, 2014; 10.1038/bjc.2014.523 Abstract | Full Text | | | | Are the studies on cancer risk from CT scans biased by indication? Elements of answer from a large-scale cohort study in France N Journy, J-L Rehel, H Ducou Le Pointe, C Lee, H Brisse, J-F Chateil, S Caer-Lorho, D Laurier and M-O Bernier Br J Cancer 2015 112: 185-193; advance online publication, October 14, 2014; 10.1038/bjc.2014.526 Abstract | Full Text | | | | Physical function as a prognostic biomarker among cancer survivors J C Brown, M O Harhay and M N Harhay Br J Cancer 2015 112: 194-198; advance online publication, November 13, 2014; 10.1038/bjc.2014.568 Abstract | Full Text | | | | Predictors of repeat participation in the NHS bowel cancer screening programme S H Lo, S Halloran, J Snowball, H Seaman, J Wardle and C von Wagner Br J Cancer 2015 112: 199-206; advance online publication, November 27, 2014; 10.1038/bjc.2014.569 Abstract | Full Text | | | | An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom L Ironmonger, E Ohuma, N Ormiston-Smith, C Gildea, C S Thomson and M D Peake Br J Cancer 2015 112: 207-216; advance online publication, December 2, 2014; 10.1038/bjc.2014.596 Abstract | Full Text | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment
Keep a civil tongue.